EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/29/2025
Back to search
Official data from USPTO
ILLUMINA COVIDSEQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ILLUMINA COVIDSEQ
ST13
US500000088983897Class
1, 5
Filing
88983897
Registration
6913584
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
11/05/2025
Trademark type
Word
Nice classes
1, 5
Filing date
04/29/2020
Registration date
11/29/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2022
Last transaction
11/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/14/2020
First use in commerce
06/09/2020
Drawing code
4
Owner type
03
Owner location
San Diego, CA
Examiner
HUSSAIN,TASNEEM
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Illumina, Inc.
Representatives
Susan M. Natland Baker & Hostetler LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use; Diagnostic reagents and preparationsother than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use in the fields of nucleic acid sequencinggenotypingdiagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiology and metagenomicsbiotechnologyagricultureforensicsfood safetygenetic testinggeneticsnot for medical or veterinary purposes; Kits comprising nucleotidesreagentsenzymesagentsassaysbufferschemical preparationsbiological preparations for scientific and research use including in the fields of nucleic acid sequencinggenotypingdiagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiology and metagenomicsbiotechnologyagricultureforensicsfood safetygenetic testinggeneticsnot for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19
Class 5
Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use; Diagnostic reagents and preparationsother than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use in the fields of nucleic acid sequencinggenotypingdiagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiology and metagenomicsbiotechnologygenetic testinggeneticsnot for medical or veterinary purposes; Kits comprising nucleotidesreagentsenzymesagentsassaysbufferschemical preparationsbiological preparations for scientific and research use including in the fields of nucleic acid sequencinggenotypingdiagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiology and metagenomicsbiotechnologygenetic testinggeneticsnot for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19
Publications
History of USPTO decisions and trademark events.
50 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/29/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/29/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/29/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/29/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/29/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/29/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/29/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/28/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
10/27/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
10/21/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/20/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/19/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2022
ALIE
ASSIGNED TO LIE
10/17/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/08/2022
GNRT
NON-FINAL ACTION E-MAILED
03/08/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/08/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/03/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
03/03/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/03/2022
IUAF
USE AMENDMENT FILED
02/16/2022
DRRR
DIVISIONAL REQUEST RECEIVED
02/16/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/16/2022
EISU
TEAS STATEMENT OF USE RECEIVED
02/16/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/03/2022
EX1G
SOU EXTENSION 1 GRANTED
02/01/2022
EXT1
SOU EXTENSION 1 FILED
02/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2021
PUBO
PUBLISHED FOR OPPOSITION
06/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/19/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/30/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/30/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/30/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/30/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/22/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/21/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/21/2020
GNRT
NON-FINAL ACTION E-MAILED
10/21/2020
CNRT
NON-FINAL ACTION WRITTEN
10/21/2020
DOCK
ASSIGNED TO EXAMINER
10/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/12/2020
NWAP
NEW APPLICATION ENTERED
05/02/2020
Continuous trademark protection
Get notified about every new filing that threatens ILLUMINA COVIDSEQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.